CSL has posted a $US2.19 billion ($A3.38 billion) net profit after tax, down three per cent from a year ago as currency fluctuations took a bite out of the blood product giant’s earnings. Adjusted for currency fluctuations, CSL’s net profit rose eight per cent to $US2.44 billion. On a constant currency basis, CSL’s revenue grew […]

This post was originally published on Michael West.